Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?

BJU Int. 2014 Mar;113(3):350-1. doi: 10.1111/bju.12493.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Renal Cell / drug therapy*
  • Everolimus
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Pneumonia / chemically induced*
  • Sirolimus / adverse effects
  • Sirolimus / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • temsirolimus
  • Everolimus
  • Sirolimus